Company Performance Metrics
- Dan Regelman: Founder & Director
Gabe Siegel: Founder & CEO
Augmentiqs is a young company with a big vision.
The end goal is an improvement in healthcare outcomes, and the way we’re going to get there is by developing the future of pathology and digital-microscopy technologies.
Augmentiqs was started with the input of the world’s leading pathologists, and focuses on developing new technologies that
integrate with and enhance the pathologist’s workflow.
Augmentiqs’ first solution is real-time telepathology and augmented microscopy, enabling online consultations, live collaboration between remote locations and more efficient investigative studies. By bridging a live, online connection between pathologists, Augmentiqs is enabling better clinical outcomes, reduced costs, and more efficient workflow.
Augmentiqs’ patent-pending technology integrates with and enhances the capabilities of all existing microscopes, capturing and sharing the live field of view and augmenting the microscope’s optical plane with interactive annotations and other digital markings by both the user and distant viewers.
Augmentiqs harnesses its expertise in telecommunications and electro-optics to deliver an ultra-HD telepathology conferencing platform that is cost-effective and intuitive to the user.
By integrating with the existing microscope and providing cost-effective collaboration tools, Augmentiqs is ushering in a new era of Smart Pathology.
